Ahead of the Hello Péro showcase at Delhi's Lakme Fashion Week, Sanrio senior execs Silvia Figini and Kiyoshi Saito sat for an exclusive interview with HT.com.
A review of the medical records of thousands of adolescents treated for obesity found that kids who received the GLP-1 medications semaglutide or liraglutide were less likely to ...